Cingulate Inc. (CING) stock

CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$4.64+0.08 (+1.75%)

Close on Nov 11, 2026Market cap $67.47MP/E –Yield –

Cingulate EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Cingulate has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?